Search by Drug Name or NDC
NDC 70069-0271-05 Verapamil Hydrochloride 2.5 mg/mL Details
Verapamil Hydrochloride 2.5 mg/mL
Verapamil Hydrochloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Somerset Therapeutics, LLC. The primary component is VERAPAMIL HYDROCHLORIDE.
Product Information
| NDC | 70069-0271 |
|---|---|
| Product ID | 70069-271_6d4f205d-626c-4285-ba7b-c0ca536c7875 |
| Associated GPIs | 34000030102005 |
| GCN Sequence Number | 000563 |
| GCN Sequence Number Description | verapamil HCl VIAL 2.5 MG/ML INTRAVEN |
| HIC3 | A9A |
| HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
| GCN | 01650 |
| HICL Sequence Number | 000180 |
| HICL Sequence Number Description | VERAPAMIL HCL |
| Brand/Generic | Generic |
| Proprietary Name | Verapamil Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Verapamil Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Labeler Name | Somerset Therapeutics, LLC |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211015 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70069-0271-05 (70069027105)
| NDC Package Code | 70069-271-05 |
|---|---|
| Billing NDC | 70069027105 |
| Package | 5 VIAL in 1 CARTON (70069-271-05) / 2 mL in 1 VIAL (70069-271-01) |
| Marketing Start Date | 2018-06-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |